Document Type : Review Articles
Authors
1 Student Research Committee, Larestan University of Medical Sciences, Larestan, Iran
2 Department of Nursing, School of Nursing, Larestan University of Medical Sciences, Larestan, Iran
3 BSc student of nursing, Student research committee, Larestan University of Medical Sciences, Larestan, Iran
Abstract
Background: Thyroid cancer is the most common malignancy of the endocrine glands at any age and sex. The present study was designed to comprehensively identify the epidemiological status of thyroid cancer using the results of similar studies.
Methods: The present study was an epidemiological review study. Studies on the epidemiology of thyroid cancer between March 2020 and April 2020 were searched by two researchers at four Latin scientific databases (Google Scholar, PubMed / Medline, Scopus, ISI Web of Science). Persian and Latin articles about the epidemiology of thyroid cancer were included in the study.
Results: The incidence of thyroid cancer is increasing worldwide; however, this type of cancer has a good survival rate. The most important risk factors for thyroid cancer include Ionizing radiation, diet, female gender, age, genetic background and race and ethnicity.
Conclusion: The incidence of thyroid cancer in the world is increasing. Therefore, preventive and protective measures to reduce the risk factors of this cancer are recommended to reduce the incidence of the disease.
Keywords
1. Mokhtari AM, Riahi S, Fathalipour M, Delam H, Hashemnejad M, Hassanipour S. The age-standardized rate of female genital cancers in Iran: a systematic review and meta-analysis. Journal of hayat. 2018;24(3):204-19.
2. Fouladseresht H, Ghorbani M, Hassanipour S, Delam H, Abdzadeh E, Mokhtari AM, Mohseni S, Riahi S, Mohammadian-Hafshejani A, Salehiniya H. The incidence of non-hodgkin lymphoma in iran: a systematic review and meta-analysis. World Cancer Research Journal. 2019;6:http-apps.
3. Lukas J, Drabek J, Lukas D, Dusek L, Gatek J. The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2013;157(3):266-75. Epub 2012/11/08.
4. Karimi N, Faradmal J, Zakavi SR, Roshanaei G, Naderi A. Assessment of Risk Factors on the Relapse and Death in Patients With Thyroid Cancer in Khorasan Razavi Province, During 2005-2015. The Journal of Qazvin University of Medical Sciences. 2019;23(2):128-39.
5. Vigneri R, Malandrino P, Vigneri P. The changing epidemiology of thyroid cancer: why is incidence increasing? Current opinion in oncology. 2015;27(1):1-7. Epub 2014/10/14.
6. Farzadfar F, Peykari N, Larijani B, Rahimzadeh S, Rezaei-Darzi E, Saeedi Moghaddam S. A comprehensive study on national and sub national trend in thyroid cancer prevalence in the iranian population, 1990–2010. Iranian Journal of Diabetes and Metabolism. 2016;15(2):91-100.
7. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. Journal of the national cancer institute. 2011;103(9):714-36.
8. Gupta-Abramson V, Troxel AB, Nellore A, Puttaswamy K, Redlinger M, Ransone K, et al. Phase II trial of sorafenib in advanced thyroid cancer. Journal of Clinical Oncology. 2008;26(29):4714.
9. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology. 2013;2013:965212. Epub 2013/06/06.
10. Dal Maso L, Lise M, Zambon P, Falcini F, Crocetti E, Serraino D, et al. Incidence of thyroid cancer in Italy, 1991–2005: time trends and age–period–cohort effects. Annals of Oncology. 2010;22(4):957-63.
11. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. International journal of cancer. 2015;136(9):2187-95.
12. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research. 2014.
13. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes & Control. 2009;20(5):525-31.
14. Wang Y, Wang W. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pacific Journal of Public Health. 2015;27(2):NP223-NP9.
15. Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Annals of oncology. 2013;24(10):2657-71.
16. Kachuri L, De P, Ellison L, Semenciw R. Cancer incidence, mortality and survival trends in Canada, 1970-2007. Chronic diseases and injuries in canada. 2013;33(2).
17. Larijani B, Aghakhani S, Khajeh-Dini H, Baradar-Jalili R. Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran. Acta Oncologica. 2003;42(4):334-7.
18. Akbari M, Abachizadeh K, Khayamzadeh M. Iran cancer report. cancer research center shahidbeheshti university of medical sciences Tehran. Qom: Darolfekr. 2008.
19. Gheriani H. Update on epidemiology classification, and management of thyroid cancer. The Libyan journal of medicine. 2006;1(1):83-95. Epub 2006/01/01.
20. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes & Control. 2009;20(1):75-86.
21. Liu FC, Lin HT, Lin SF, Kuo CF, Chung TT, Yu HP. Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer. Oncotarget. 2017;8(45):78429-51. Epub 2017/11/08.
22. Tsuda T, Tokinobu A, Yamamoto E, Suzuki E. Thyroid cancer detection by ultrasound among residents ages 18 years and younger in Fukushima, Japan: 2011 to 2014. Epidemiology (Cambridge, Mass). 2016;27(3):316.
23. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA: a cancer journal for clinicians. 2012;62(2):118-28.
24. Al-Lawati NA, Shenoy SM, Al-Bahrani BJ, Al-Lawati JA. Increasing Thyroid Cancer Incidence in Oman: A Joinpoint Trend Analysis. Oman medical journal. 2020;35(1):e98. Epub 2020/02/26.
25. Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update. Thyroid. 2014;24(2):190-9.
26. Kitahara CM, Platz EA, Freeman LEB, Hsing AW, Linet MS, Park Y, et al. Obesity and thyroid cancer risk among US men and women: a pooled analysis of five prospective studies. Cancer Epidemiology and Prevention Biomarkers. 2011;20(3):464-72.
27. Zhao Z, Guo X, Ba C, Wang W, Yang Y, Wang J, et al. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. Journal of International Medical Research. 2012;40(6):2041-50.
28. Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Medical science monitor: international medical journal of experimental and clinical research. 2015;21:283.
29. Cossu A, Budroni M, Paliogiannis P, Palmieri G, Scognamillo F, Cesaraccio R, et al. Epidemiology of thyroid cancer in an area of epidemic thyroid goiter. Journal of cancer epidemiology. 2013;2013:584768. Epub 2013/03/28.
30. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama. 2006;295(18):2164-7.
31. Husson O, Haak HR, van Steenbergen LN, Nieuwlaat W-A, van Dijk BA, Nieuwenhuijzen GA, et al. Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endocrine-related cancer. 2013;20(2):263-71.
32. Hershman JM. The increased incidence of thyroid cancer is worldwide. Clinical Thyroidology. 2017;29(1):11-2.
33. Khodamoradi F, Ghoncheh M, Mehri A, Hassanipour S, Salehiniya H. Incidence, mortality, and risk factors of thyroid cancer in the world: A review. World Cancer Research Journal. 2018;5(2):9.
34. Raposo L, Morais S, Oliveira MJ, Marques AP, José Bento M, Lunet N. Trends in thyroid cancer incidence and mortality in Portugal. European Journal of Cancer Prevention. 2017;26(2):135-43.
35. Knobel M, Medeiros-Neto G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arquivos Brasileiros de Endocrinologia & Metabologia. 2007;51(5):701-12.
36. Pettersson B, Coleman MP, Ron E, Adami HO. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. International journal of cancer. 1996;65(1):13-9.
37. Williams E, Doniach I, Bjarnason O, Michie W. Thyroid cancer in an iodide rich area. A histopathological study. Cancer. 1977;39(1):215-22.
38. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PloS one. 2012;7(1).
39. Memon A, Varghese A, Suresh A. Benign thyroid disease and dietary factors in thyroid cancer: a case–control study in Kuwait. British journal of cancer. 2002;86(11):1745-50.
40. Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, et al. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid. 2011;21(9):957-63.
41. Takezaki T, Hirose K, Inoue M, Hamajima N, Kuroishi T, Nakamura S, et al. Risk factors of thyroid cancer among women in Tokai, Japan. Journal of epidemiology. 1996;6(3):140-7.
42. Yu G-P, Li JC-L, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid. 2010;20(5):465-73.
43. Magreni A, Bann DV, Schubart JR, Goldenberg D. The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngology–Head & Neck Surgery. 2015;141(4):319-23.
44. Aschebrook-Kilfoy B, Kaplan EL, Chiu BC-H, Angelos P, Grogan RH. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Annals of surgical oncology. 2013;20(8):2746-53.
45. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2013;23(1):103-10. Epub 2012/10/10.
46. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer research and treatment: official journal of Korean Cancer Association. 2015;47(2):127.
47. Safavi A, Jafari R, Chaibakhsh S, Ramezani-Daryasar R, Rezaei M, Safavi AA. Recent Trends and Geographical Distribution of Thyroid Cancer in Iran from 2004 to 2009. Iranian journal of cancer prevention. 2014;7(4):212-8. Epub 2015/09/24.
48. Hassanipour S, Delam H, Arab-Zozani M, Abdzadeh E, Hosseini SA, Nikbakht H-A, et al. Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis. Annals of global health. 2020;86(1).
49. Ellison LF, Bushnik T. Changing trends in thyroid cancer incidence in Canada: A histologic examination, 1992 to 2016. Health reports. 2020;31(1):15-25. Epub 2020/01/16.
50. Goldust M, Sokouti M, Montazeri V, Fakhrjoo A, Samankan S. A clinical epidemiologic study of thyroid carcinoma in patients under 25 years old in Tabriz, Iran (1995-2010). JPMA The Journal of the Pakistan Medical Association. 2012;62(11):1265-8.
51. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.
)